Two cases of treating chemotherapy-induced peripheral neurotoxicity（CIPN） with Wenjing Huayu Tongluo formula
Article Sidebar
Main Article Content
Abstract
The Wen Jing Hua Yu Tong Luo Formula is an experienced prescription by Professor Xu Zhenye, a renowned traditional Chinese medicine doctor in Shanghai. The combination of herbs is precise and appropriate, including prineipal herb scorpio，assoeiate herb ligusticum wallichii and adjuvant herb cassia twig. It excels in dispersing, promoting blood circulation, and warming the meridians, and is consistent with the differentiation of yang deficiency and blood stasis in peripheral neuropathy. There are countless cases of improving peripheral neuropathy in patients. This article presents two cases.
Article Details
References
Oneda E, Abeni C, Zanotti L, Zaina E, Bighe S, Zaniboni A. Chemotherapy-induced neurotoxicity in the treatment of gynecological cancers: state of art and an innovative approach for prevention. World J Clin Oncol. 2021;12(6):458-67.
Cascella M, Muzio MR. Potential application of the Kampo medicine goshajinkigan for prevention of chemotherapy-induced peripheral neuropathy. J Integr Med. 2017;15(2):77-87.
Rao ZJ, Deng HB, Zhu LM, Shi HX, Xu ZY. Research progress of chemotherapy-induced peripheral neurotoxicity. Modernization of Traditional Chinese Medicine and Materia Medica-World Science and Technology. 2020;22(4):1307-14. (in Chinese)
Meng J, Zhu J. Research progress of traditional Chinese medicine on treatment of peripheral neuropathy. Journal of Nanjing University of Traditional Chinese Medicine. 2018;34(6):634-8. (in Chinese)
Xu PP. Analysis of traditional Chinese medicine constitution characteristics in patients with peripheral neuropathy induced by chemotherapy drugs [Master]. Oncology. Beijing: Beijing Traditional Chinese Medicine. 2019. (in Chinese)
Su ZJ, Chai N, Zhu HR. A review of research on traditional Chinese medicine diagnosis and treatment of chemotherapy induced peripheral neuropathy. Chinese Archives of Traditional Chinese Medicine. 2020;38(4):196-200. (in Chinese)
Shu HX, Rao ZJ, Zhu LM, Lu YY, Yang XL, Gai Y, et al. Clinical effect of Yiqi Wenyang Tongmai formula on patients with chemotherapy induced peripheral neuropathy. Academic Journal of Shanghai University of Traditional Chinese Medicine. 2022;36(2):13-19. (in Chinese)
Zlotecki RA, Scarborough MT, Morris CG, Berrey BH, Lind DS, Enneking WF, et al. External beam radiotherapy for primary and adjuvant management of aggressive fibromatosis. Int J Radiat Oncol Biol Phys. 2002;54(1):177-81.
Chugh R, Wathen JK, Patel SR, Maki RG, Meyers PA, Schuetze SM, et al. Efficacy of imatinib in aggressive fibromatosis: results of a phase II multicenter Sarcoma Alliance for Research through Collaboration (SARC) trial. Clin Cancer Res. 2010;16(19):4884-91.
Smith EM, Pang H, Cirrincione C, Fleishman S, Paskett ED, Ahles T, et al. Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial. JAMA. 2013;309(13):1359-67.
Durand JP, Deplanque G, Montheil V, Gornet JM, Scotte F, Mir O, et al. Efficacy of venlafaxine for the prevention and relief of oxaliplatin-induced acute neurotoxicity: results of EFFOX, a randomized, double-blind, placebo-controlled phase III trial. Ann Oncol. 2012;23(1):200-5.
Song M, Meng Y, Ren XH, Chang ZW, Chang J, Li L. Effects and mechanism of venlafaxine on neuropathic pain induced by oxaliplatin. Cancer Research on Prevention and Treatment. 2013;40(6):555-9. (in Chinese)
